The EGFR-STYK1-FGF1 axis sustains drug tolerance to EGFR inhibitors in non-small cell lung cancer

  • Carolien Eggermont (Speaker)

Activity: Talk or presentation › Talk or presentation at a conference

Period28 Jun 2022 → 1 Jul 2022
Event titlePersistent cancer cell: Molecular mechanisms, dynamic models
towards therapy
Event typeWorkshop
LocationCroatiaShow on map